AnaptysBio, Inc. (NASDAQ: ANAB) reported Q4 EPS of ($0.72), $0.90 better than the analyst estimate of ($1.62). Revenue for the quarter came in at $43.11 million versus the consensus estimate of $8.44 million.

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.